News
But he wasn’t about to let mitochondrial disease Leber’s hereditary optic neuropathy (LHON) stand in his way, and he made his first appearance as part of Italy’s Paralympic team in 2016 ...
It’s hard to imagine suddenly losing your sight in your 20s, but that’s what happened to Richard Wheeler when he developed Leber’s hereditary optic neuropathy (LHON). People with LHON ...
was developed to address LHON and has been evaluated in four prior clinical studies, demonstrating early improvements. The ...
GenSight Biologics’ lead product candidate, GS010, is in Phase III trials in Leber Hereditary Optic Neuropathy (LHON), a rare mitochondrial disease that leads to irreversible blindness in teens ...
The study also showed that a point mutation in complex I associated with Leber hereditary optic neuropathy (LHON) ...
One such disease where patients may benefit is Leber Hereditary Optic Neuropathy (LHON), an inherited eye disease affecting approximately 600,000 people worldwide and 100,000 people in China.
GenSight Biologics’ lead product candidate, GS010 (lenadogene nolparvovec) is in Phase III in Leber Hereditary Optic Neuropathy (LHON), a rare mitochondrial disease that leads to irreversible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results